Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial
-
Published:2024-05
Issue:
Volume:191
Page:107538
-
ISSN:0169-5002
-
Container-title:Lung Cancer
-
language:en
-
Short-container-title:Lung Cancer
Author:
Pu Xingxiang,
Xiao Zemin,
Li Jia,
Wu Zhijun,
Ma Zhongxia,
Weng Jie,
Xiao Maoliang,
Chen Yanhua,
Cao Yongqing,
Cao Peiguo,
Wang Qianzhi,
Xu Yan,
Li Kang,
Chen Bolin,
Xu Fang,
Liu Liyu,
Kong Yi,
Zhang Hui,
Duan Huaxin,
Wu LinORCID